Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
Recruiting now
Conditions studied: Obesity (Disorder), Anti-obesity Agents, Precision Medicine
In brief
Obesity is a chronic multifactorial disease with a strong genetic component. Although glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists, such as tirzepatide, are highly effective treatments for obesity, substantial inter-individual variability in weight loss response remains. Genetic factors may contribute to these differences in treatment outcomes. The aim of this prospective cohort study is to investigate whether a Genetic Risk Score (GRS) and selected obesity-related single nucleotide polymorphisms (SNPs) can predict weight loss response to semaglutide or tirzepatide in adults with obesity. Participants initiating treatment with either medication will undergo clinical, biochemical, and genetic assessment at baseline and will be followed for six months. The study will evaluate the association between genetic markers and treatment response and develop predictive models integrating genetic and clinical variables. The findings may contribute to the development of personalized treatment strategies for obesity.
Key facts
- Study ID
- NCT07653412
- Run by
- National and Kapodistrian University of Athens
- People needed
- 220
- Starts
- 2026-04-22
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2026-07-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years
- BMI ≥40 kg/m² or ≥37 kg/m² with comorbidities
- Initiation of semaglutide or tirzepatide
You may not qualify if…
- Prior bariatric surgery
- Secondary causes of obesity
- Active malignancy
- Chronic pancreatitis
- Family history of medullary thyroid carcinoma
Where it is running
- Laiko General Hospital, Athens — Athens, Greece (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.